Related Experiment Videos
Drug-induced early and late proarrhythmia
1University of Pennsylvania School of Medicine, Philadelphia.
Cardiology Clinics
|August 1, 1992
Summary
Drug therapy can provoke new or worsen existing arrhythmias, known as proarrhythmia. Early and late proarrhythmic events are recognized, impacting the crucial benefit-risk assessment for drug safety.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Trials
Background:
- Proarrhythmia is drug-induced arrhythmia.
- Early toxic effects of drugs can manifest as new or worsened arrhythmias.
- Recognized categories include primary/secondary proarrhythmia and early event types (fatal, serious, nonserious).
Purpose of the Study:
- To define and characterize early and late proarrhythmic events.
- To emphasize the importance of proarrhythmia in drug benefit-risk assessment.
Main Methods:
- Review of definitions for early proarrhythmic events.
- Analysis of placebo-controlled trials to define late proarrhythmic events (enhanced arrhythmic death).
Main Results:
- Specific definitions exist for early proarrhythmic events.
- Late proarrhythmic events, or enhanced arrhythmic death, have been defined.
- Proarrhythmic responses are critical for benefit-risk evaluation.
Conclusions:
- Understanding and identifying both early and late proarrhythmic events is essential.
- Accurate assessment of proarrhythmia is key to safe and effective drug therapy.
- The benefit-risk ratio hinges on evaluating drug-induced arrhythmias.